Co-sensitization and cross-reactivity of Blomia tropicalis with two Dermatophagoides species in Guangzhou, China.


Journal

Journal of clinical laboratory analysis
ISSN: 1098-2825
Titre abrégé: J Clin Lab Anal
Pays: United States
ID NLM: 8801384

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 27 02 2019
revised: 28 06 2019
accepted: 01 07 2019
pubmed: 22 7 2019
medline: 17 4 2020
entrez: 21 7 2019
Statut: ppublish

Résumé

Contradictory results have been reported previously in the analyses of cross-reactivity among Blomia tropicalis (Blo t), Dermatophagoides pteronyssinus (Der p), and Dermatophagoides farinae (Der f). This study aims to investigate the characteristics of co-sensitization and the IgE cross-reactivity among them and attempts to identify whether patients are sensitized to Blo t due to cross-reaction or true sensitization. Specific IgE (sIgE) in the sera from 1497 allergenic patients was determined by ImmunoCAP. Cross-reactivity was analyzed and determined by sIgE inhibition with 21 sera samples. Around 85.50% of patients were sensitized to Der p, 85.37% of patients were sensitized to Der f, and 71.54% of patients were sensitized to Blo t. Further, 70.14% of patients were co-sensitized to Blo t, Der p, and Der f, and only seven patients were sensitized solely to Blo t. With increasing sIgE levels for Blo t, the positive rates of severe-level (class 5-6) co-sensitization to Der p or Der f significantly increased. Blo t was moderately associated with Der p and Der f, with correlation coefficients of 0.6998 and 0.6782, respectively. Der p and Der f inhibited IgE binding to Blo t more strongly than Blo t inhibited IgE binding to Der p or Der f in the patient groups C This study has established valuable information about the co-sensitization and cross-reactivity of Blo t with two Dermatophagoides species (Der p and Der f) and helps to provide adequate diagnosis and treatment of the mite-allergic patients.

Sections du résumé

BACKGROUND BACKGROUND
Contradictory results have been reported previously in the analyses of cross-reactivity among Blomia tropicalis (Blo t), Dermatophagoides pteronyssinus (Der p), and Dermatophagoides farinae (Der f). This study aims to investigate the characteristics of co-sensitization and the IgE cross-reactivity among them and attempts to identify whether patients are sensitized to Blo t due to cross-reaction or true sensitization.
METHODS METHODS
Specific IgE (sIgE) in the sera from 1497 allergenic patients was determined by ImmunoCAP. Cross-reactivity was analyzed and determined by sIgE inhibition with 21 sera samples.
RESULTS RESULTS
Around 85.50% of patients were sensitized to Der p, 85.37% of patients were sensitized to Der f, and 71.54% of patients were sensitized to Blo t. Further, 70.14% of patients were co-sensitized to Blo t, Der p, and Der f, and only seven patients were sensitized solely to Blo t. With increasing sIgE levels for Blo t, the positive rates of severe-level (class 5-6) co-sensitization to Der p or Der f significantly increased. Blo t was moderately associated with Der p and Der f, with correlation coefficients of 0.6998 and 0.6782, respectively. Der p and Der f inhibited IgE binding to Blo t more strongly than Blo t inhibited IgE binding to Der p or Der f in the patient groups C
CONCLUSIONS CONCLUSIONS
This study has established valuable information about the co-sensitization and cross-reactivity of Blo t with two Dermatophagoides species (Der p and Der f) and helps to provide adequate diagnosis and treatment of the mite-allergic patients.

Identifiants

pubmed: 31325210
doi: 10.1002/jcla.22981
pmc: PMC6868408
doi:

Substances chimiques

Allergens 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e22981

Subventions

Organisme : Open Project of State Key Laboratory of Respiratory Disease
ID : SKLRD-OP-201803
Organisme : Open Project of State Key Laboratory of Respiratory Disease
ID : SKLRD-OP-201809
Organisme : Science and Technology Innovation Committee Project of Guangzhou
ID : 201831802
Organisme : Bureau of traditional Chinese Medicine Scientific Research Project of Guangdong
ID : 20192048
Organisme : National Natural Science Foundation of China
ID : 81601394
Organisme : National Natural Science Foundation of China
ID : 81802076
Organisme : National Natural Science Foundation of China
ID : 81871736

Informations de copyright

© 2019 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc.

Références

Allergy. 1999 Nov;54(11):1150-9
pubmed: 10604550
Chin Med J (Engl). 2012 Sep;125(17):3059-63
pubmed: 22932181
Biomed Environ Sci. 2015 Oct;28(10):709-17
pubmed: 26582093
Allergy. 1998 Sep;53(9):821-32
pubmed: 9788682
Asian Pac J Allergy Immunol. 2010 Mar;28(1):1-6
pubmed: 20527509
Asia Pac Allergy. 2015 Apr;5(2):78-83
pubmed: 25938072
Asian Pac J Allergy Immunol. 2012 Dec;30(4):294-300
pubmed: 23393909
Allergy. 2009 Jul;64(7):1083-92
pubmed: 19210346
J Allergy Clin Immunol. 2001 Jun;107(6):977-84
pubmed: 11398074
Allergol Immunopathol (Madr). 2006 Jan-Feb;34(1):23-6
pubmed: 16540067
Rev Alerg Mex. 2012 Jul-Sep;59(3):107-12
pubmed: 24007986
J Clin Lab Anal. 2019 Nov;33(9):e22981
pubmed: 31325210
PLoS One. 2014 May 01;9(5):e94776
pubmed: 24787549
Mol Immunol. 2019 Jan;105:38-45
pubmed: 30481720
J Asthma. 2010 Oct;47(8):849-52
pubmed: 20846087
Exp Appl Acarol. 2009 Feb;47(2):159-72
pubmed: 18850281
Am J Rhinol Allergy. 2018 Sep;32(5):397-403
pubmed: 30001632
J Investig Allergol Clin Immunol. 2015;25(5):343-51
pubmed: 26727763
Mol Med Rep. 2015 Oct;12(4):5467-74
pubmed: 26238285

Auteurs

Xiaoqing Liu (X)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Department of Clinical Laboratory and Medical Research Center, Zhuhai Hospital of Jinan University, Zhuhai, China.

Peiyan Zheng (P)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Song Guo Zheng (SG)

Department of Medicine at Penn State College of Medicine and Milton S. Hershey Medical Center, Hershey, Pennsylvania.

Yingying Zhai (Y)

Department of Paediatrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Xiaoming Zhao (X)

Department of Otolaryngology Head and Neck Surgery, Zhuhai Hospital of Jinan Universality, Zhuhai, China.

Yin Chen (Y)

Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ, USA.

Chuanxu Cai (C)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Zehong Wu (Z)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Zhifeng Huang (Z)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Xiangwei Zou (X)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Chenxi Liao (C)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Baoqing Sun (B)

Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH